Question

I am a breastfeeding mother and i want to know if it is safe to use UNII-WI6V529FZ9? Is UNII-WI6V529FZ9 safe for nursing mother and child? Does UNII-WI6V529FZ9 extracts into breast milk? Does UNII-WI6V529FZ9 has any long term or short term side effects on infants? Can UNII-WI6V529FZ9 influence milk supply or can UNII-WI6V529FZ9 decrease milk supply in lactating mothers?

Answer by DrLact: About UNII-WI6V529FZ9 usage in lactation

No information is available on the clinical use of UNII-WI6V529FZ9 during breastfeeding. Because UNII-WI6V529FZ9's half-life is about 39 hours, it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during UNII-WI6V529FZ9 therapy and for 1 month after the last dose.

Alternate Drugs

Vinorelbine(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Alemtuzumab(Low Risk)
Rituximab(Low Risk)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Mitoxantrone(Dangerous)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Dactinomycin(Dangerous)
Nilotinib(Unsafe)
Letrozole(Dangerous)
Erlotinib(Unsafe)
Hydroxyurea(Low Risk)
Exemestane(Dangerous)
Etoposide(Dangerous)
Trastuzumab(Unsafe)
Doxorubicin(Dangerous)
Cyclophosphamide(Dangerous)
Pazopanib(Unsafe)
Docetaxel(Dangerous)
Cisplatin(Unsafe)
Imatinib(Unsafe)
Ipilimumab(Unsafe)
Busulfan(Dangerous)
Nivolumab(Unsafe)
Cetuximab(Unsafe)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Bleomycin(Dangerous)
Paclitaxel(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.